Emergent BioSolutions

Emergent hid COVID-19 vaccine problems from FDA, report finds
Beckers Hospital Review
Tue, 05/10/22 - 10:31 pm
Emergent BioSolutions
vaccines
COVID-19
government contracts
The 12 Top Biotech Companies Hiring Now
BioSpace
Tue, 05/10/22 - 10:26 pm
biotech
life sciences
hirings
Regeneron
Pfizer
Amgen
AbbVie
Moderna Therapeutics
CSL Behring
Waters Corporation
Daiichi Sankyo
Gilead Sciences
Grail
Emergent BioSolutions
resilience
It looks like the final round of Emergent's AstraZeneca Covid-19 doses have been released
Endpoints
Tue, 02/22/22 - 11:12 pm
Emergent BioSolutions
AstraZeneca
COVID-19
vaccines
Court sides with Teva over Emergent in generic Narcan suit
Endpoints
Tue, 02/15/22 - 11:36 pm
Teva Pharmaceutical
legal
Emergent BioSolutions
generics
Narcan
opioids
Teva and Novartis’ Sandoz launch Narcan generics on same day, brand marketer Emergent remains in play
Endpoints
Wed, 01/5/22 - 10:47 pm
Teva Pharmaceutical
Novartis
Sandoz
generics
Narcan
Emergent BioSolutions
Emergent loses out on $180M as U.S. cancels COVID-19 vaccine production contract
Fierce Pharma
Sun, 11/7/21 - 10:44 pm
Emergent BioSolutions
COVID-19
vaccines
drug manufacturing
50 Million J&J Vaccine Doses Found Idle in Baltimore Plant
BioSpace
Thu, 10/28/21 - 10:11 pm
JNJ
vaccines
Baltimore
Emergent BioSolutions
Emergent wins FDA all-clear to restart J&J COVID-19 vaccine production in Baltimore
Fierce Pharma
Fri, 07/30/21 - 11:13 am
Emergent BioSolutions
vaccines
JNJ
drug manufacturing
FDA
Biotech Company That Botched Vaccines Faces Investor Revolt
NY Times, NY
Tue, 07/6/21 - 11:01 am
Emergent BioSolutions
investors
vaccines
COVID-19
FDA authorizes more J&J vaccines made at Emergent plant
Beckers Hospital Review
Wed, 06/16/21 - 11:31 pm
FDA
vaccines
JNJ
Emergent BioSolutions
The F.D.A. tells Johnson & Johnson that about 60 million doses made at troubled plant cannot be used.
NY Times, NY
Fri, 06/11/21 - 12:12 pm
JNJ
vaccines
COVID-19
drug manufacturing
FDA
Emergent BioSolutions
Emergent BioSolutions Announces Positive Two-Year Persistence Data From Phase 2 Study Evaluating CHIKV VLP, the Company’s Chikungunya Virus Virus-Like Particle Vaccine Candidate
Drugs.com
Mon, 05/31/21 - 07:04 pm
Emergent BioSolutions
clinical trials
vaccines
chikungunya virus
J&J homes in on manufacturing restart at Emergent plant behind 15M discarded COVID-19 doses
Fierce Pharma
Sat, 05/29/21 - 05:16 pm
Emergent BioSolutions
JNJ
drug manufacturing
vaccines
COVID-19
5 takeaways from Emergent BioSolutions' congressional testimony
Beckers Hospital Review
Thu, 05/20/21 - 11:15 pm
Emergent BioSolutions
JNJ
vaccines
testimony
House committee grills Emergent CEO Bob Kramer over J&J vaccine debacle, ill-timed stock sale
Endpoints
Thu, 05/20/21 - 11:13 am
Emergent BioSolutions
FDA
drug manufacturing
JNJ
vaccines
COVID-19
Emergent BioSolutions leaders to testify before Congress
Beckers Hospital Review
Wed, 05/12/21 - 11:37 pm
Emergent BioSolutions
vaccines
COVID-19
US Congress
Emergent CEO defends company from criticism of error that ruined vaccine doses
BioPharma Dive
Fri, 04/30/21 - 10:37 am
Emergent BioSolutions
JNJ
vaccines
COVID-19
Emergent CEO sold more than $10 million in stock before scrapping J&J COVID-19 vaccine doses: report
Fierce Pharma
Mon, 04/26/21 - 11:05 pm
Emergent BioSolutions
JNJ
vaccines
COVID-19
FDA of­fers scathing re­view of Emer­gent plan­t's san­i­tary con­di­tions, em­ploy­ee train­ing af­ter halt­ing pro­duc­tion
Endpoints
Wed, 04/21/21 - 10:36 am
FDA
Emergent BioSolutions
regulatory inspections
drug manufacturing
vaccines
FDA orders shutdown at Emergent's troubled plant 2 weeks after handing J&J the keys
Fierce Pharma
Mon, 04/19/21 - 11:16 am
Emergent BioSolutions
drug manufacturing
vaccines
FDA
COVID-19

Pages